Flucytosine Catalog No.:M9399-2 KU-60019 treatment (3 μM) blocks

KU-60019 treatment (3 μM) blocks basal and insulin-induced AKT S473 phosphorylation by 70% and ~50%

Ikarisoside A inhibited the activity of p38 kinase and nuclear factor-kappaB (NF-kappaB)

CAS Number: 612487-72-6

7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

1401966-63-9 (meso)

Flucytosine Catalog No.:M9399-2 KU-60019 treatment (3 μM) blocksFlucytosine, a fluorinated pyrimidine analogue, is a synthetic antimycotic drug. It is structurally related to the cytostatic fluorouracil and to floxuridine. Oral flucytosine is indicated for the treatment of serious infections caused by susceptible strains of Candida or Cryptococcus neoformans. It can also be used for the treatment of chromomycosis (chromoblastomycosis), if susceptible strains cause the infection. Product information CAS Number: